A Study in Patients With Myasthenia Gravis in China

Active, not recruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 26, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Myasthenia Gravis
Trial Locations (20)

Unknown

Research Site, Beijing

Research Site, Chengdu

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Guiyang

Research Site, Harbin

Research Site, Hebei

Research Site, Henan

Research Site, Inner Mongolia

Research Site, Jiangsu

Research Site, Lanzhou

Research Site, Nanning

Research Site, Qingdao

Research Site, Taiyuan

Research Site, Tianjin

Research Site, Ürümqi

Research Site, Wenzhou

Research Site, Wuhan

Research Site, Xi'an

Research Site, Yinchuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY